Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$17,023,511
+$3,762,268 QoQ
Shares Held
14,193
-1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#971
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Palisade Asset Management, LLC holds $93,677,669 across 8 Drug Manufacturers - General names. LLY ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,776 | $26,353,645 | |
| 2 | JNJ |
Johnson & Johnson
|
100,872 | $25,618,461 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
14,193 | $17,023,511 | |
| 4 | ABBV |
AbbVie Inc.
|
62,276 | $15,671,132 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,395 | $4,548,257 | |
| 6 | NVS |
Novartis AG
|
15,639 | $2,450,944 | |
| 7 | PFE |
Pfizer Inc
|
44,085 | $1,061,566 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,490 | $950,153 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,023,511 | 14,193 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $13,261,243 | 14,418 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $15,826,813 | 14,727 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,412,307 | 18,889 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $14,283,328 | 18,323 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $15,145,537 | 18,338 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $14,712,776 | 19,058 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,894,875 | 19,070 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,411,362 | 19,231 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $17,511,101 | 22,509 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $13,237,530 | 22,709 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,074,682 | 22,480 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $10,637,873 | 22,683 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,789,795 | 22,683 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,298,348 | 22,683 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,334,548 | 22,683 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,354,509 | 22,683 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $6,495,730 | 22,683 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $6,500,285 | 23,533 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,518,167 | 23,883 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,481,626 | 23,883 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,480,504 | 23,983 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $4,041,860 | 23,939 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,558,252 | 24,039 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,110,903 | 25,039 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $3,560,110 | 25,664 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||